Acura Pharma's (ACUR) LTX 04 Receives FDA Fast Track Designation

Share on Facebook Share on Twitter

Upgrade to StreetInsider Premium! - Free Trial

Source : http://www.streetinsider.com/Corporate News/Acura Pharmas (ACUR) LTX-04 Receives FDA Fast Track Designation/11495550.html

Thanks for visit my website
Share on Facebook Share on Twitter
Acura Pharma's (ACUR) LTX-04 Receives FDA Fast Track Designation
Acura Pharmaceutical's Limitx(TM) Technology Successfully Demonstrates Oral Abuse Deterrence
Acura Pharmaceuticals' (ACUR) CEO Bob Jones on Q2 2016 Results - Earnings Call Transcript
ACURA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acura Pharmaceutical's LIMITX(TM) Technology Successfully Confirms Oral Abuse Deterrence Capabilities
Acura Pharmaceuticals' (ACUR) CEO Bob Jones on Q3 2016 Results - Earnings Call Transcript